Abiopharma

Reports 2025 Financial Results and Provides Corporate Updat

Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence

INVESTOR NOTICE: Gartner, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

JZXN to Deliver 100 Electric Heavy-Duty Trucks to Vietnam Market

Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence

WeRide Reports Record Full Year 2025 Revenue of RMB684.6 Million, Up 90% Year over Year

FORM 20-F For the fiscal year ended December 31, 2025

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics

Banc of California, Inc. Extends $300 Million Stock Repurchase Program and Announces Intent to Redeem Outstanding Fixed-to-Floating Rate Subordinated Notes due 2031

SMCI INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Super Micro Computer, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm